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Key messages
 ► Use of barrier methods was higher in 
short-term relationships among younger 
participants, but this was not seen 
among the oldest respondents.
 ► Relationship duration was more strongly 
associated with the contraceptive 
method used than was self-defined 
status of relationship, and this pattern 
was more obvious among younger 
participants.
 ► Asking about partnership characteristics 
may help providers support women in 
their use of contraception by considering 
their priorities and preferences at 
different life stages.
AbstrAct
Background One in six pregnancies in Britain 
are unplanned. An understanding of influences 
on contraceptive method choice is essential to 
provision compatible with users’ lifestyles. This 
study describes contraceptive method use by 
age, and relationship status and duration, among 
women in Britain.
Methods Data from women participating 
in the third British National Survey of Sexual 
Attitudes and Lifestyles were used to describe 
contraceptive use grouped as: unreliable 
method or none; barrier methods; oral/injectable 
hormonal methods; and long-acting reversible 
contraception. A total of 4456 women at risk of 
pregnancy were used to examine associations 
between contraception use, age, relationship 
type and duration. Age-stratified odds ratios 
for contraceptive use by relationship type and 
duration were estimated using binary logistic 
regression.
Results Some 26.0% of 16–49-year-olds 
used hormonal contraception as their usual 
method. Use of hormonal and barrier methods 
was highest in the youngest age group and 
decreased with age; the reverse was true for use 
of unreliable methods or none. Barrier method 
use was higher in short-term relationships 
among younger participants; this was not seen 
among older respondents. Duration was more 
strongly associated with usual contraceptive 
method than relationship type; this pattern was 
more marked among younger participants.
Conclusions Asking about relationship status 
and duration may help providers support 
women’s contraceptive use by considering their 
priorities and preferences at different life stages. 
Interactions between relationship characteristics, 
age and contraception are complex, and bear 
closer scrutiny both in research and in policy and 
practice.
bAckground
An estimated 16% of pregnancies in Britain 
are unplanned.1 Since contraception is 
available free of charge under National 
Health Service provision, and the preva-
lence of contraceptive use is high, efforts 
to reduce this number need to extend 
beyond addressing non-use. The risk 
of unplanned pregnancy resulting from 
method discontinuation has been shown 
to be almost as high as that resulting from 
no method use.2 Consequently, an under-
standing of influences on method choice 
is essential to contraceptive provision 
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Figure 1 Contraceptive methods grouped by type.
compatible with users’ lifestyles, and so less likely to 
be discontinued. 
Studies in the United States (US) have shown both 
age3 4 and relationship characteristics to be more 
strongly associated with contraceptive method than 
other demographic factors.5 Contraceptive use has 
been associated with the number of sexual partners 
in Australia and Europe,6–9 the quality and level of 
trust in relationships,5 10 and type of relationship in 
Britain and the US.11–16 Other US studies and one in 
Britain have shown that condom use decreases with 
the relationship duration,11–14 17 18 while hormonal 
method use increases.13–16 19 Other studies have 
shown use of any method increases with relationship 
duration.10 15 18
To date, no studies using large, representative 
samples of women have examined how associations 
between method use and relationship characteristics 
differ by age group, or have distinguished between 
relationship duration and type. Further, few have 
taken account of fertility intentions.13 20 21 The aim of 
this study was twofold: first, to describe contraceptive 
method use among women in Britain in 2010–2012 
by age group, and second, to examine associations 
in different age groups between type of partnership, 
duration of relationship, and contraceptive method 
use by women (reporting in 2010–2012) at risk of 
unintended pregnancy. The study uses data from the 
third National Survey of Sexual Attitudes and Life-
styles (Natsal-3).
Methods
study design and setting
Data were analysed from Natsal-3, a cross-sectional 
survey of 15 162 16–74-year-old men and women 
living in Britain, interviewed between September 2010 
and August 2012 (response rate 57.7%). The survey 
used a multistage, clustered and stratified probability 
sample. Natsal-3 data were weighted to adjust for the 
unequal probabilities of selection and a non-response 
post-stratification weight was applied.22
Natsal-3 was approved by the Oxfordshire Research 
Ethics Committee A (reference: 09/H0604/27).
Participants
Female Natsal-3 participants of ‘reproductive age’ 
(aged 16 to 49 years),23 were included in initial anal-
yses of contraceptive method use (and stratified by 
age group) for whom usual contraceptive method was 
reported (n=5857). To explore patterns of method use 
by relationship type and duration by age group, we 
excluded those currently pregnant, trying to conceive 
or menopausal (n=802), those who had not had 
heterosexual sex in the recent time period (n=89), 
and participants who relied on sterilisation (n=379) 
(as few such women existed in the two younger age 
groups). We also excluded women who did not report 
year of both first and most recent occasions of sex 
with their most recent partner (n=129), or relation-
ship status with their most recent partner (n=2). After 
applying these criteria, the analysis included 4456 
women (online supplementary files 1 and 2).
Measures
Outcomes
The primary outcome was the contraceptive method 
usually used. Responses to the question ‘Which would 
you say is your most usual (contraceptive) method 
these days?’ were grouped into four categories (indi-
cating type of method, as opposed to grouping based 
on effectiveness): unreliable or no usual method; 
barrier methods; oral/injectable hormonal; and long-
acting reversible contraceptives (LARC) (figure 1). 
Participants were allowed to select up to three usual 
methods. For the 261 women who indicated use of 
more than one method, the most effective method 
reported was coded as their usual method.
Exposure variables
Relationship duration was calculated from the dates 
of first and most recent occasion of sex with the most 
recent sexual partner and grouped into mutually 
exclusive categories: 1 day (where the dates of first and 
last sex were the same); more than 1 day to 6 months; 
6 months to 1 year; 1 to 3 years; 3 to 5 years; and 
5 years or more.
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Table 1 ‘Usual’ contraceptive method use among women aged 16–49 years, stratified by age (column percentages)
Total
Age range (years)
16–24 25–34 35–49 Unweighted Weighted
n % (95% CI) n % (95% CI) n % (95% CI) n n % (95% CI)
Unreliable method or 
none 126 7.6 (6.3 to 9.2) 295 12.3 (10.9 to 13.9) 352 19.4 (17.4 to 21.5) 773 655 14.8 (13.6 to 16.0)
Barrier methods 357 22.1 (19.9 to 24.4) 400 18.0 (16.2 to 20.0) 234 12.9 (11.4 to 14.6) 991 727 16.4 (15.3 to 17.5)
Oral/injectable methods 768 45.5 (42.7 to 48.2) 832 33.2 (31.2 to 35.2) 244 13.2 (11.5 to 15.0) 1844 1154 26.0 (24.8 to 27.3)
LARC 220 12.1 (10.4 to 13.9) 287 11.4 (10.0 to 13.0) 193 11.3 (9.8 to 13.1) 700 511 11.5 (10.5 to 12.6)
Male or female 
sterilisation 3 0.2 (0.1 to 0.6) 87 3.6 (2.8 to 4.5) 280 18.5 (16.4 to 20.7) 370 449 10.1 (9.1 to 11.3)
Not sexually active† 36 2.5 (1.7 to 3.5) 121 4.2 (3.5 to 5.0) 159 6.8 (5.7 to 8.1) 316 226 5.1 (4.5 to 5.8)
Only same-sex 
experience‡ 14 1.0 (0.6 to 1.6) 24 1.0 (0.6 to 1.5) 23 1.3 (0.8 to 1.9) 61 49 1.1 (0.8 to 1.5)
Currently pregnant§ or 
menopausal 160 9.2 (7.8 to 10.8) 359 16.3 (14.7 to 18.1) 283 16.7 (14.8 to 18.8) 802 666 15.0 (13.9 to 16.2)
Total
  Unweighted 1684 28.8 2405 41.1 1768 30.2 5857 100
  Weighted 939 21.2 (20.1 to 22.2) 1331 30.0 (28.8 to 31.3) 2167 48.8 (47.3 to 50.4) 4437 100
Proportions are weighted to account for the survey sampling design and non-response.
Total N includes women aged 16–49 years, who reported their usual method of contraception. One woman reported her usual method of contraception as an emergency method and was excluded from 
these results.
†Not sexually active in the last year.
‡Only same-sex sexual experience in the last year.
§Includes women currently pregnant or trying to conceive.
CI, confidence interval ;LARC, long-acting reversible contraception.
Relationship status was derived from the question 
‘Which one of these descriptions applies best to you 
and [that person/name] at the time you most recently 
had sex?’ Responses were grouped into four mutually 
exclusive categories: recently met, not steady, steady 
but non-cohabiting, married/cohabiting.
statistical analyses
Initial analyses described the association between 
contraceptive method group usually used and age group 
(16–24, 25–34 and 35–49 years), including those with 
limited recent heterosexual sexual experience and those 
currently pregnant. From this point, further analyses 
were restricted to women at risk of unplanned preg-
nancy (those not answering ‘I would definitely like 
(more) children and am currently trying’ to a fertility 
intention question, those pre-menopausal, and those 
with recent heterosexual activity). A cross-tabulation of 
contraceptive method type usually used and relationship 
status and duration showed trends in method use by 
relationship characteristics in different age groups.
Use of each category of contraceptive method was 
indicated in four dichotomous variables whereby usual 
use of the method of interest was coded ‘1’, else ‘0’. 
These dichotomous variables were the dependent vari-
ables in binary logistic regression models. Initially each 
binary logistic regression model predicted the crude 
(univariable) odds of use of the method of interest by 
relationship status and duration, followed by mutual 
adjustment for both partnership characteristic variables.
Statistical analyses were performed using Stata/SE 15 
(StataCorp LP) taking into account the survey’s sample 
design, using the svy function.
results
contraceptive method use among all women, by age
Table 1 shows usual contraceptive method, sexual 
activity and pregnancy status among all women aged 
16–49 years, stratified by age group. Only 6.2% had 
not had sex with a man in the year prior to interview, 
and 15.0% were either currently pregnant, trying to 
conceive or menopausal, totalling 21.2% unlikely 
to have been at risk of unintended pregnancy. The 
methods most commonly used by those at risk were 
oral/injectable hormonal methods (26.0%), barrier 
methods (16.4%), and unreliable methods or none 
(14.8%). Use of hormonal methods was highest in 
the youngest age group, decreasing with successive 
age group. The reverse was true for unreliable and no 
method use, which increased with age group. Reliance 
on sterilisation also increased with age group and was 
reported by almost one in five 35–49-year-olds, but by 
virtually no 16–24-year-olds.
contraceptive method use by age and relationship 
characteristics among women at risk of unintended 
pregnancy
Online supplementary file 3 gives the distribution of 
women by partnership characteristics. Table 2 shows 
contraceptive method group use by partnership char-
acteristics by age group (online supplementary file 
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4 provides the crude odds ratios and online supple-
mentary file 5 gives additional descriptive analyses of 
condom use by partnership characteristics).
16–24-year-olds
Unreliable and no method(s)
Less than 10% of 16–24-year-olds at risk of unintended 
pregnancy were using an unreliable or no contracep-
tive method. This proportion did not vary consistently 
by relationship status but decreased significantly with 
duration. After adjustment for relationship status and 
duration, the association between use of an unreliable 
method or none and relationship duration remained 
significant, but the association with relationship status 
was weakened (figure 2A and online supplementary file 
6).
Barrier methods
Barrier method use was reported by one in four 
women at risk of unintended pregnancy, but decreased 
significantly as relationships increased in length and 
became more established. After adjustment, the odds 
of barrier method use were only significantly lower 
for women in relationships lasting 1 to 3 years’ dura-
tion, and among women in steady or married/cohab-
iting relationships.
Oral and injectable methods
Hormonal method use accounted for over half of usual 
use by women at risk of unintended pregnancy. Use was 
highest among women in relationships of 1 to 3 years’ 
duration and those in ‘steady’ relationships. Adjusted 
odds showed significant increased use of oral/injectable 
methods in relationships lasting between 6 months and 
3 years, as well as among steady, non-cohabiting couples.
LARC
The proportion of women using LARC did not vary with 
relationship duration nor status in this age group, and 
this was confirmed in the adjusted logistic regression 
results.
25–34-year-olds
Unreliable and no method(s)
Almost one-fifth of women in this age group used an 
unreliable or no method. This proportion increased 
with relationship duration but not status. Adjusted 
results showed a significant decrease in use of unre-
liable methods or none for all relationships lasting 
longer than 1 day (with the exception of relationships 
of 6 months to 1 year) (figure 2B).
Barrier methods
Almost one-quarter of women at risk of unintended 
pregnancy usually used a barrier method. This propor-
tion did not vary significantly by relationship charac-
teristics. After adjustment, only women whose most 
recent relationship lasted between 3 and 5 years were 
less likely to report use of barrier methods.
Oral and injectable methods
The proportion of women reporting oral/injectable 
method use increased with relationship duration but 
did not vary significantly by status. After adjustment, 
use of these methods significantly increased with rela-
tionship duration, but notably, decreased with rela-
tionship stability. Women whose most recent relation-
ship had lasted only 1 day were less likely than other 
women to use hormonal methods, but women who 
said they had recently met their partner were more 
likely than married/cohabiting women to have used 
such methods.
LARC
There were no significant associations between use of 
LARC and relationship duration or status.
35–49-year-olds
Unreliable and no method(s)
Some 38.1% of women in this age group reported 
usual use of an unreliable or no method. This propor-
tion varied by relationship status but not duration. 
Adjusted odds ratios showed women who had recently 
met their partner were less likely to use an unreliable 
or no method (figure 2C).
Barrier methods
Use of barrier methods varied with neither relation-
ship status nor duration.
Oral and injectable methods
The adjusted odds of using an oral or injectable 
method were not significantly associated with relation-
ship status nor duration.
LARC
Use of LARC varied significantly by relationship status, 
but not duration. After adjustment, women who had 
recently met their partner were significantly more likely 
to use LARC than women in other types of relationship.
discussion
Principal findings
These data from a nationally-representative survey 
of sexually-active women in Britain illustrate differ-
ences in method use by the nature and duration of the 
relationship with the most recent sexual partner and 
how the extent of these differences varies with age. Use 
of barrier methods was appreciably higher in short-term 
than longer-term relationships among younger partic-
ipants, but this pattern was not seen among respond-
ents in the oldest age group. While there was consider-
able correspondence between the duration and type of 
relationships and their association with contraceptive 
method use, some differences were observed. Rela-
tionship duration was marginally more strongly asso-
ciated with the contraceptive method used than was 
relationship type, and this pattern was more obvious 
among younger participants. Moreover, relationship 
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Figure 2 Forest plots of adjusted odds ratios for use of each group of contraceptive methods, by relationship duration and relationship status. A: 16–24 
years; B: 25–34 years; C: 35–49 years.
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type and duration operated differentially in their influ-
ence on hormonal method use among 25–34-year-old 
women.
Comparison of our findings to those of other studies 
is difficult because of differences in methodology, in 
the definition of relationship types and in the categori-
sation of contraceptive methods. Typically, studies that 
have compared contraceptive method use in different 
age groups,4 24 have not taken relationship characteris-
tics into account and, conversely, studies that compared 
contraceptive method use by relationship characteristics 
have not done so in different age groups.6–10 13 14 16 25 
These differences in study design are likely to partially 
explain the equivocal nature of findings of many previous 
studies14 and also apparent anomalies between other 
studies and our own. At the aggregate level, we did not 
find higher levels of LARC use among younger partici-
pants than older ones, as others have.26 27 Nevertheless, 
their use increased markedly among 16–24-year-old 
women whose relationship had lasted 5 or more years; 
equivalent to the prevalence among 35–49-year-olds.
study strengths and weaknesses
Our large population-based dataset enabled us to esti-
mate the prevalence of contraceptive use in different age 
groups by relationship type and duration, and to exclude 
women not apparently at risk of unplanned pregnancy. 
The study also has limitations. For multi-partnered 
participants, cross-sectional data are unsuited to tracing 
pathways of use and consequently we have made several 
assumptions in this article. First, we have assumed that 
respondents used their ‘usual’ method of contraception 
with their most recent sexual partner. When respondents 
reported several usual methods, the most effective may 
not have been the method used for the most recent sex. 
Second, the most recent sexual partner may not have 
been the main sexual partner during the previous year. 
Relationship duration was calculated objectively as the 
time between first and most recent sex with the respond-
ent’s most recent sexual partner. This measure might not 
truly reflect relationship duration as it would be defined 
by the participant. We restricted our analyses to women, 
as misreporting of usual contraceptive method may be 
more common by men, since the majority of the methods 
are operationalised by women. We were limited to use of 
data generated by the questions asked in Natsal-3, which 
did not probe affective attributes of the relationship 
which others have linked to contraceptive method use.5 10 
Finally, while we have no reason to believe contraceptive 
practices might have changed in the time since interview, 
these analyses are based on data reported by participants 
up to 8 years ago.
implications for policy and practice
Our data should be interpreted in the context of women’s 
lives, and their evolving priorities and preoccupations 
through the life course. Younger women, and those in 
more transient relationships, may be more motivated 
to avoid pregnancy than those who are older and in 
more stable relationships. Thus, the fact that one in six 
16–24-year-olds uses an unreliable/no method of contra-
ception with a partner they have just met is of concern. So, 
also, is the relatively low prevalence of reliable method 
use in shorter-term relationships among older partici-
pants. Alternatively, it is likely that although not explic-
itly trying to conceive, for some women a pregnancy 
would not be unwelcome, resulting in some ambivalence 
in relation to contraceptive use.28 An acknowledgement 
of pregnancy intention as a continuum is important to 
further understand women’s contraceptive needs. To 
date, sexual health policy remains focused on younger 
adults, but evidence that the majority of unplanned preg-
nancies occur among women aged 25 years and over,1 
has prompted pleas for age-specific health promotion 
strategies.29 30
The independent associations of relationship type 
and duration with method use, and the suggestion that 
duration might be the stronger influence, has implica-
tions for policy and practice. Conventionally in clinical 
record-taking, data are collected on relationship type. 
Our findings suggest that there are benefits to be gained 
from asking about relationship duration in helping 
support women in their use of contraception, to help 
them consider their priorities and preferences at different 
life stages. Our findings highlight the complex nature of 
associations between age, partnership characteristics and 
method use, and signify that every woman needs to be 
assessed individually.
Future research
Future research should recognise that the associations 
between relationship characteristics and contraceptive 
method use are more complex than might be suggested 
from aggregate data often used to assess the need for 
health promotional messages and public health inter-
ventions. Studies need to take account of both age and 
the nature of the relationships in which women use 
contraception.
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